P833: CATEGORIZING HEMATOLOGICAL RESPONSE TO PEGCETACOPLAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: A POST HOC ANALYSIS OF THE PHASE 3 PRINCE STUDY DATA

• A. Risitano,
• R. Wong,
• M. Al-Adhami,
• J. Savage,
• R. Horneff,
• R. Peffault de Latour

Affiliations

A. Risitano

1 Hematology and BMT Unit, AORN, San Giuseppe Moscati, Avellino, Italy

R. Wong

2 Sir Y.K. Pao Centre for Cancer & Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Sha Tin, Hong Kong

M. Al-Adhami

3 Apellis Pharmaceuticals, Inc., Waltham, United States of America

J. Savage

3 Apellis Pharmaceuticals, Inc., Waltham, United States of America

R. Horneff

4 Swedish Orphan Biovitrum AB, Stockholm, Sweden

R. Peffault de Latour

5 French Reference Center for Aplastic Anemia and Paroxysmal Noctural Hemoglobinuria, Assistance Publique - Hôpitaux de Paris; Université de Paris, Paris, France